Dhulia, I., Patel, H., Chauhan, N. and Pardeshi, N. (2021) “FDA’s drug regulatory pathways, its development strategies and regulatory considerations”, International Journal of Drug Regulatory Affairs, 9(2), pp. 6-15. doi: 10.22270/ijdra.v9i2.460.